CDMO: EUROAPI Supports Sanofi's mRNA Vaccine Platform with the Development of Lipid Nanoparticles

EUROAPI is a global leader in lipid nanoparticles with strong expertise in its Budapest and Frankfurt Development, Pilot and Manufacturing sites Sanofi decided to expand its collaboration

Related Keywords

Maupas ,Midi Pyrées ,France ,Budapest ,Hungary ,Paris ,France General ,Frankfurt ,Brandenburg ,Germany ,Guillaume Rosso ,Kai Rossen ,Laurence Bollack ,Frankfurt Development ,Contract Development ,French Financial Markets Authority Autorit ,Manufacturing Services ,Euronext ,Manufacturing Organization ,Master Agreement For Development ,Master Agreement ,Good Manufacturing Practices ,Chief Scientific Officer ,French Financial Markets Authority ,Relations Contact ,Cdmo ,Euroapi ,Supports ,Sanofi ,Rna ,Vaccine ,Platform ,Development ,Ipid ,Anoparticles ,